Free Trial

Edgewise Therapeutics (EWTX) Short Interest Ratio & Short Volume

Edgewise Therapeutics logo
$30.78 -0.02 (-0.06%)
(As of 12/20/2024 05:16 PM ET)

Edgewise Therapeutics Short Interest Data

Edgewise Therapeutics (EWTX) has a short interest of 5.74 million shares, representing 9.20% of the float (the number of shares available for trading by the public). This marks a -10.17% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.2, indicating that it would take 5.2 days of the average trading volume of 941,777 shares to cover all short positions.

Current Short Interest
5,740,000 shares
Previous Short Interest
6,390,000 shares
Change Vs. Previous Month
-10.17%
Dollar Volume Sold Short
$189.42 million
Short Interest Ratio
5.2 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
94,689,000 shares
Float Size
62,410,000 shares
Short Percent of Float
9.20%
Today's Trading Volume
1,110,575 shares
Average Trading Volume
941,777 shares
Today's Volume Vs. Average
118%
Short Selling Edgewise Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Edgewise Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EWTX Short Interest Over Time

EWTX Days to Cover Over Time

EWTX Percentage of Float Shorted Over Time

Edgewise Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/20245,740,000 shares $189.42 million -10.2%9.2%5.2 $33.00
11/15/20246,390,000 shares $200.90 million -12.4%10.2%5.8 $31.44
10/31/20247,290,000 shares $244.73 million -14.1%12.2%6.2 $33.57
10/15/20248,490,000 shares $280.09 million -9.1%14.3%7 $32.99
9/30/20249,340,000 shares $249.28 million +14.3%15.8%8.1 $26.69
9/15/20248,170,000 shares $153.84 million +5.0%14.0%6.8 $18.83
8/31/20247,780,000 shares $145.88 million +21.6%13.3%9 $18.75
8/15/20246,400,000 shares $120.77 million -20.8%11.0%7.6 $18.87
7/31/20248,080,000 shares $137.60 million -5.8%13.6%9.8 $17.03
7/15/20248,580,000 shares $196.22 million +1.2%14.5%11.2 $22.87
6/30/20248,480,000 shares $152.72 million +11.3%14.3%11.5 $18.01
6/15/20247,620,000 shares $133.43 million +17.2%11.6%12.7 $17.51
5/31/20246,500,000 shares $111.35 million -1.4%9.9%9.6 $17.13
5/15/20246,590,000 shares $116.51 million +1.1%10.0%9.2 $17.68
4/30/20246,520,000 shares $116.97 million +13.2%10.4%8.9 $17.94
4/15/20245,760,000 shares $94.92 million +0.7%9.2%7.6 $16.48
3/31/20245,720,000 shares $104.33 million +27.7%9.1%5.7 $18.24
3/15/20244,480,000 shares $75.80 million -18.0%7.1%4.3 $16.92
2/29/20245,460,000 shares $89.16 million +6.4%9.1%5.6 $16.33
2/15/20245,130,000 shares $93.98 million -5.0%8.6%5.4 $18.32
1/31/20245,400,000 shares $96.28 million -33.9%11.5%6.3 $17.83
1/15/20248,170,000 shares $81.70 million -12.5%22.7%10.8 $10.00
12/31/20239,340,000 shares $102.18 million +9.9%25.9%20.1 $10.94
12/15/20238,500,000 shares $61.97 million +20.9%23.7%22.6 $7.29
11/30/20237,030,000 shares $42.74 million +11.1%19.6%24.7 $6.08
11/15/20236,330,000 shares $41.52 million +5.3%17.7%34.2 $6.56
10/31/20236,010,000 shares $38.46 million +4.5%17.0%35.9 $6.40
10/15/20235,750,000 shares $38.58 million +1.6%16.3%36.2 $6.71
9/30/20235,660,000 shares $32.43 million +2.2%16.1%33.2 $5.73
9/15/20235,540,000 shares $35.57 million +1.7%15.7%28.2 $6.42
8/31/20235,450,000 shares $34.06 million +1.1%13.9%26.9 $6.25
8/15/20235,390,000 shares $39.35 million -1.3%13.8%24.5 $7.30
7/31/20235,460,000 shares $39.80 million -12.1%13.7%24.8 $7.29
7/15/20236,210,000 shares $44.84 million +11.7%15.6%27.4 $7.22
6/30/20235,560,000 shares $43.09 million +3.5%14.0%26.4 $7.75
6/15/20235,370,000 shares $46.83 million +12.6%13.5%25 $8.72
5/31/20234,770,000 shares $48.27 million +5.8%12.0%25.3 $10.12
5/15/20234,510,000 shares $40.68 million +1.8%11.3%25.8 $9.02
4/30/20234,430,000 shares $38.85 million +6.2%11.0%25.6 $8.77
4/15/20234,170,000 shares $24.23 million +4.5%10.3%26.5 $5.81
Forced out of retirement by these trades (Ad)

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available 
3/31/20233,990,000 shares $26.61 million +6.1%9.9%25.1 $6.67
3/15/20233,760,000 shares $28.76 million -2.1%9.3%25.4 $7.65
2/28/20233,840,000 shares $36.79 million +1.6%9.5%22.4 $9.58
2/15/20233,780,000 shares $37.76 million -2.3%9.3%21.3 $9.99
1/31/20233,870,000 shares $39.59 million +29.9%9.6%21.5 $10.23
1/15/20232,980,000 shares $32.93 million -25.7%7.4%15.8 $11.05
12/30/20224,010,000 shares $35.85 million +38.8%10.0%20 $8.94
12/15/20222,890,000 shares $22.46 million -16.2%7.2%13.3 $7.77
11/30/20223,450,000 shares $30.88 million -3.1%8.6%11.8 $8.95
11/15/20223,560,000 shares $37.38 million -1.1%8.9%12 $10.50
10/31/20223,600,000 shares $34.24 million +8.4%8.9%12.1 $9.51
10/15/20223,320,000 shares $34.59 million +19.0%10.4%10.9 $10.42
9/30/20222,790,000 shares $27.45 million +5.3%10.2%9.2 $9.84
9/15/20222,650,000 shares $24.19 million -12.3%9.7%8.3 $9.13
8/31/20223,020,000 shares $30.44 million -17.0%10.8%12.3 $10.08
8/15/20223,640,000 shares $39.17 million +3.7%13.1%14.7 $10.76
7/31/20223,510,000 shares $33.94 million +3.2%12.5%13.5 $9.67
7/15/20223,400,000 shares $34.54 million +9.0%12.1%13.3 $10.16
6/30/20223,120,000 shares $24.84 million -3.1%11.1%12.6 $7.96
6/15/20223,220,000 shares $19.90 million +1.6%11.5%13.2 $6.18
5/31/20223,170,000 shares $19.81 million -16.1%11.3%14.8 $6.25
5/15/20223,780,000 shares $29.60 million -3.3%13.6%16.7 $7.83
4/30/20223,910,000 shares $31.20 million +1.8%14.0%18.4 $7.98
4/15/20223,840,000 shares $33.48 million -5.9%13.8%16.5 $8.72
3/31/20224,080,000 shares $39.58 million -2.9%14.7%14.7 $9.70
3/15/20224,200,000 shares $42.97 million -10.6%15.1%10.8 $10.23
2/28/20224,700,000 shares $55.41 million +4.7%16.9%10.2 $11.79
2/15/20224,490,000 shares $58.95 million +12.5%18.6%9.8 $13.13
1/31/20223,990,000 shares $54.26 million +8.7%16.5%9.1 $13.60
1/15/20223,670,000 shares $64.23 million +4.6%N/A8.8 $17.50
12/31/20213,510,000 shares $53.63 million +31.0%14.5%9.2 $15.28
12/15/20212,680,000 shares $51.97 million +24.1%11.1%11.8 $19.39
11/30/20212,160,000 shares $37.63 million +45.0%8.9%16.8 $17.42
11/15/20211,490,000 shares $29.25 million +7.2%6.1%15.6 $19.63
10/29/20211,390,000 shares $22.94 million -12.0%5.9%16.7 $16.50
10/15/20211,580,000 shares $28.03 million No Change6.7%23.5 $17.74
9/30/20211,580,000 shares $26.23 million -1.3%6.7%17.2 $16.60
9/15/20211,600,000 shares $25.39 million -23.8%6.9%12.1 $15.87
8/31/20212,100,000 shares $33.26 million +2.4%9.0%12.6 $15.84
8/13/20212,050,000 shares $33.33 million No Change8.8%11 $16.26

EWTX Short Interest - Frequently Asked Questions

What is Edgewise Therapeutics' current short interest?

Short interest is the volume of Edgewise Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 5,740,000 shares of EWTX short. 9.20% of Edgewise Therapeutics' shares are currently sold short. Learn More on Edgewise Therapeutics' current short interest.

What is a good short interest ratio for Edgewise Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EWTX shares currently have a short interest ratio of 5.0. Learn More on Edgewise Therapeutics's short interest ratio.

Which institutional investors are shorting Edgewise Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edgewise Therapeutics: Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Edgewise Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.20% of Edgewise Therapeutics' floating shares are currently sold short.

Is Edgewise Therapeutics' short interest increasing or decreasing?

Edgewise Therapeutics saw a decline in short interest in November. As of November 30th, there was short interest totaling 5,740,000 shares, a decline of 10.2% from the previous total of 6,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Edgewise Therapeutics' float size?

Edgewise Therapeutics currently has issued a total of 94,689,000 shares. Some of Edgewise Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edgewise Therapeutics currently has a public float of 62,410,000 shares.

How does Edgewise Therapeutics' short interest compare to its competitors?

9.20% of Edgewise Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Edgewise Therapeutics: Dr. Reddy's Laboratories Limited (1.32%), Sarepta Therapeutics, Inc. (6.09%), Catalent, Inc. (8.12%), Vaxcyte, Inc. (8.85%), Qiagen (1.68%), Intra-Cellular Therapies, Inc. (1.64%), Roivant Sciences Ltd. (12.55%), Ascendis Pharma A/S (6.22%), Revolution Medicines, Inc. (9.61%), Lantheus Holdings, Inc. (6.73%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Edgewise Therapeutics stock?

Short selling EWTX is an investing strategy that aims to generate trading profit from Edgewise Therapeutics as its price is falling. EWTX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Edgewise Therapeutics?

A short squeeze for Edgewise Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EWTX, which in turn drives the price of the stock up even further.

How often is Edgewise Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EWTX, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:EWTX) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners